Accelerating cell and gene therapies for rare diseases: ARM Studios interview with Julia Jenkins

The cost of living with a rare disease is often overlooked when weighing the impact of cell and gene therapies. Stephen Majors, ARM’s Global Head of Communications, sits down with Julia Jenkins, Board President of the EveryLife Foundation, to discuss how cell and gene therapies are transforming patients’ lives. #CGMesa23 #cellandgenetherapy

Скачать видео